Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
varlitinib epidermal growth factor receptor small molecule Successful target TTD , drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]
Biliary Tract Neoplasm[MeSHID:D001661]		 0.54 investigational,phase 2/3 inhibitor
varlitinib epidermal growth factor receptor small molecule Successful target TTD , drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]
Biliary Tract Neoplasm[MeSHID:D001661]		 0.54 investigational,phase 2/3 unknown
varlitinib erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]
Biliary Tract Neoplasm[MeSHID:D001661]		 0.85 phase 2/3 unknown
varlitinib receptor tyrosine-protein kinase erbb-2 small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]
Biliary Tract Neoplasm[MeSHID:D001661]		 0.85 investigational inhibitor
varlitinib receptor tyrosine-protein kinase erbb-2 small molecule NA drugbank , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]
Biliary Tract Neoplasm[MeSHID:D001661]		 0.85 investigational unknown
varlitinib erbb2 tyrosine kinase receptor NA Successful target TTD , DGIDB Neoplasms[MeSHID:D009369]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]
Biliary Tract Neoplasm[MeSHID:D001661]		 0.85 phase 2/3 inhibitor
click here to return to the previous page